<li>alfentanil<p>alfentanil, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>amitriptyline<p>escitalopram and amitriptyline both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>amoxapine<p>escitalopram and amoxapine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>apixaban<p>escitalopram and apixaban both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>bupropion<p>escitalopram increases toxicity of bupropion by unspecified interaction mechanism. Avoid or Use Alternate Drug. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>buspirone<p>escitalopram and buspirone both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>citalopram<p>citalopram and escitalopram both increase  serotonin levels. Avoid or Use Alternate Drug. Combination may increase risk of serotonin syndrome or neuroleptic malignant syndrome-like reactions. ECG monitoring is recommended, along with drugs that may prolong the QT interval.</p></li><li>clarithromycin<p>clarithromycin, escitalopram.
Either increases toxicity of the other by QTc interval. Avoid or Use Alternate Drug. To monitor for the prolongation of QT/QTc and/or development  of ventricular tachyarrhythmias the labeling recommends monitoring QT interval or ECG.</p></li><li>clomipramine<p>escitalopram and clomipramine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>cyclobenzaprine<p>escitalopram and cyclobenzaprine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>desipramine<p>escitalopram and desipramine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>desvenlafaxine<p>escitalopram and desvenlafaxine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>dextromethorphan<p>escitalopram and dextromethorphan both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>dolasetron<p>dolasetron, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>dosulepin<p>escitalopram and dosulepin both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>doxepin<p>escitalopram and doxepin both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>duloxetine<p>duloxetine and escitalopram both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fentanyl<p>fentanyl, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fentanyl intranasal<p>fentanyl intranasal, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fentanyl iontophoretic transdermal system<p>fentanyl iontophoretic transdermal system, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fentanyl transdermal<p>fentanyl transdermal, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fentanyl transmucosal<p>fentanyl transmucosal, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fluoxetine<p>fluoxetine will increase the level or effect of escitalopram by  affecting hepatic enzyme CYP2C19 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>escitalopram and fluoxetine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fluvoxamine<p>fluvoxamine will increase the level or effect of escitalopram by  affecting hepatic enzyme CYP2C19 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>escitalopram and fluvoxamine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>granisetron<p>granisetron, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>histrelin<p>histrelin increases toxicity of escitalopram by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>hydromorphone<p>hydromorphone, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>idelalisib<p>idelalisib will increase the level or effect of escitalopram by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Idelalisib is a strong CYP3A inhibitor; avoid coadministration with sensitive CYP3A substrates</p></li><li>imipramine<p>escitalopram and imipramine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>ivacaftor<p>ivacaftor increases levels of escitalopram by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Ivacaftor and its M1 metabolite has the potential to inhibit CYP3A4, may significantly increase systemic exposure to   3A4 substrates.</p></li><li>levomilnacipran<p>escitalopram and levomilnacipran both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>linezolid<p>linezolid and escitalopram both increase  serotonin levels. Avoid or Use Alternate Drug. Linezolid may increase serotonin as a result of MAO-A inhibition. If linezolid must be administered, discontinue serotonergic drug immediately and monitor for CNS toxicity. Serotonergic therapy may be resumed 24 hours after last linezolid dose or after 2 weeks of monitoring, whichever comes first.</p></li><li>lofepramine<p>escitalopram and lofepramine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>lorcaserin<p>escitalopram and lorcaserin both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>maprotiline<p>escitalopram and maprotiline both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>mefloquine<p>mefloquine increases toxicity of escitalopram by QTc interval. Avoid or Use Alternate Drug. Mefloquine may enhance the QTc prolonging effect of high risk QTc prolonging agents.</p></li><li>meperidine<p>escitalopram and meperidine both increase  serotonin levels. Avoid or Use Alternate Drug.<span><br><br></span>meperidine, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>methylene blue<p>methylene blue and escitalopram both increase  serotonin levels. Avoid or Use Alternate Drug. Methylene blue may increase serotonin as a result of MAO-A inhibition. If methylene blue must be administered, discontinue serotonergic drug immediately and monitor for CNS toxicity. Serotonergic therapy may be resumed 24 hours after last methylene blue dose or after 2 weeks of monitoring, whichever comes first.</p></li><li>metoclopramide<p>metoclopramide and escitalopram both increase  serotonin levels. Avoid or Use Alternate Drug. Additive effects; increased risk for serotonin syndrome, neuroleptic malignant syndrome, dystonia, or other extrapyramidal reactions</p></li><li>mianserin<p>escitalopram and mianserin both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>milnacipran<p>escitalopram and milnacipran both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>morphine<p>morphine, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>nafarelin<p>nafarelin increases toxicity of escitalopram by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>nefazodone<p>escitalopram and nefazodone both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>netupitant/palonosetron<p>netupitant/palonosetron, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>nortriptyline<p>escitalopram and nortriptyline both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>ondansetron<p>escitalopram and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.<span><br><br></span>ondansetron, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>palonosetron<p>palonosetron, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>panobinostat<p>escitalopram and panobinostat both increase  QTc interval. Avoid or Use Alternate Drug. Panobinostat is known to significantly prolong QT interval. Panobinostat prescribing information states use with drugs known to prolong QTc is not recommended.</p></li><li>paroxetine<p>escitalopram and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>phentermine<p>escitalopram, phentermine.
Either increases toxicity of the other by Mechanism: unknown. Avoid or Use Alternate Drug. Risk of serotonin syndrome.</p></li><li>pimozide<p>pimozide, escitalopram. Mechanism: unknown. Contraindicated. Risk of long QT syndrome.</p></li><li>protriptyline<p>escitalopram and protriptyline both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>rasagiline<p>rasagiline and escitalopram both increase  serotonin levels. Avoid or Use Alternate Drug. Severe CNS toxicity associated with hyperpyrexia has been reported with the combined treatment of an antidepressant and rasagiline. Avoid combination within 14 days of MAOI use.</p></li><li>remifentanil<p>remifentanil, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>selegiline transdermal<p>selegiline transdermal and escitalopram both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>sertraline<p>escitalopram and sertraline both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>st john's wort<p>escitalopram and st john's wort both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>sufentanil<p>sufentanil, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>sufentanil sl<p>sufentanil sl, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>tedizolid<p>tedizolid, escitalopram.
Either increases effects of the other by Mechanism: pharmacodynamic synergism. Avoid or Use Alternate Drug. both increase serotonin levels; increased risk of serotonin syndrome.</p></li><li>trazodone<p>escitalopram and trazodone both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>trimipramine<p>escitalopram and trimipramine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>triptorelin<p>triptorelin increases toxicity of escitalopram by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>umeclidinium bromide/vilanterol inhaled<p>escitalopram increases toxicity of umeclidinium bromide/vilanterol inhaled by QTc interval. Avoid or Use Alternate Drug. Exercise extreme caution when vilanterol coadministered with drugs that prolong QTc interval; adrenergic agonist effects on the cardiovascular system may be potentiated.</p></li><li>vandetanib<p>escitalopram, vandetanib.
Either increases toxicity of the other by QTc interval. Avoid or Use Alternate Drug. Avoid coadministration with drugs known to prolong QT interval;  if a drug known to prolong QT interval must be used, more frequent ECG monitoring is recommended.</p></li><li>vemurafenib<p>vemurafenib and escitalopram both increase  QTc interval. Avoid or Use Alternate Drug. Concomitant use of vemurafenib with drugs that  prolong QT interval is not recommended.</p></li><li>venlafaxine<p>escitalopram and venlafaxine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>vilanterol/fluticasone furoate inhaled<p>escitalopram increases toxicity of vilanterol/fluticasone furoate inhaled by QTc interval. Avoid or Use Alternate Drug. Exercise extreme caution when vilanterol coadministered with drugs that prolong QTc interval; adrenergic agonist effects on the cardiovascular system may be potentiated.</p></li><li>vilazodone<p>escitalopram, vilazodone.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug. Concomitant therapy should be discontinued immediately if signs or symptoms of serotonin syndrome emerge and supportive symptomatic treatment should be initiated.  .</p></li><li>vortioxetine<p>escitalopram increases toxicity of vortioxetine by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>warfarin<p>escitalopram increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li>